Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.210
-0.010 (-0.82%)
Jan 21, 2025, 4:00 PM EST - Market closed
EDIT's stock price has decreased by -85.04% in the past year and price targets may not have had time to catch up.
Editas Medicine Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$8.08
Upside
+567.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +313.22% | Dec 16, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Dec 16, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +230.58% | Dec 13, 2024 |
| Barclays | Barclays | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +147.93% | Dec 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 13, 2024 |
| Baird | Baird | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +561.16% | Dec 13, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $11 → $3 | Strong Buy → Hold | Downgrades | $11 → $3 | +147.93% | Dec 13, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $7 → $4 | Buy → Hold | Downgrades | $7 → $4 | +230.58% | Dec 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +891.74% | Nov 5, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $8 → $5 | Hold | Maintains | $8 → $5 | +313.22% | Nov 5, 2024 |
| Stifel | Stifel | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +809.09% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | +561.16% | Nov 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +478.51% | Nov 5, 2024 |
| Barclays | Barclays | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +313.22% | Nov 5, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $3 | Hold | Maintains | $7 → $3 | +147.93% | Oct 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $27 → $9 | Buy | Maintains | $27 → $9 | +643.80% | Oct 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.